- Associate Professor in Pharmacy Practice, University of Bradford
Prescription drug shortages can have a significant effect on quality of life for patients.
The development of new weight loss drugs is one way that patient access can be ensured in the future.
Alongside COVID and the flu, cases of norovirus and RSV are already surging this year.
The weight loss drug is even more effective than Wegovy.
People are increasingly being asked to pay for services they could once access as part of the NHS for free.
Drugs for menopause, ADHD and type 2 diabetes were all in short supply this year.
An increase in global demand for ADHD drugs is one reason for ongoing shortages.
Ongoing shortages of the drug have been reported in the UK, Australi and Ireland.
Many common medications – including those prescribed for menopause, dementia, and depression – are currently seeing shortages worldwide.
Current supply shortages may also be a problem for people in palliative care or receiving cancer treatment.
They’re often no more effective than placebo, but that shouldn’t necessarily stop us using them.
Contact Jonathan for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Location: Bradford, United Kingdom
- Website
- X (formerly Twitter): @jon_silcock
- Article Feed
- ORCID
- Joined










